Establishment Labs Holdings Inc.
NCM: ESTALive Quote
About Establishment Labs Holdings Inc.
Healthcare
Medical Devices
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.
📊 Fundamental Analysis
Establishment Labs Holdings Inc. demonstrates a profit margin of -24.2%, which is below the sector average, suggesting competitive pressure.
The company recently reported 45.2% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -133.3%, which indicates that capital utilization is currently under pressure.
At a current price of $60.19, ESTA currently sits at the 58th percentile of its 52-week range (Range: $28.67 - $83.31).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$2.35B
Trailing P/E
--
Forward P/E
293.61
Beta (5Y)
1.08
52W High
$83.31
52W Low
$28.67
Avg Volume
517K
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App